23/10/2024, 3:22:03 pm

Buy Rossari Biotech; target of Rs 1034: KR Choksey

KR Choksey's research report on Rossari Biotech. Rossari Biotech reported lower than expected topline and bottom line Q2FY25 due to softer HPPC growth and material weakness in TSC segment. Despite these pressures , it posted 3.1%/12%/3.2%/7.2% revenue /GP/EBITDA/PAT growth on YOY basis led by heathy export growth in the HPPC segment.